ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 29 filers reported holding ALLENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 3,053 | +2.9% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 2,968 | +0.5% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 2,952 | +107.4% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 1,423 | +13.3% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 1,256 | +2.5% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 1,225 | -0.1% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 1,226 | +7.5% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 1,140 | +5.1% | 0.00% | – |
Q2 2020 | $2,000 | -33.3% | 1,085 | -65.9% | 0.00% | – |
Q1 2020 | $3,000 | -62.5% | 3,185 | +2.7% | 0.00% | – |
Q4 2019 | $8,000 | -83.3% | 3,100 | -74.6% | 0.00% | – |
Q3 2019 | $48,000 | 0.0% | 12,189 | +3.7% | 0.00% | – |
Q2 2019 | $48,000 | -68.0% | 11,751 | -44.9% | 0.00% | – |
Q1 2019 | $150,000 | +97.4% | 21,311 | +51.9% | 0.00% | – |
Q4 2018 | $76,000 | +5.6% | 14,028 | +110.3% | 0.00% | – |
Q3 2018 | $72,000 | +63.6% | 6,669 | +95.1% | 0.00% | – |
Q2 2018 | $44,000 | -57.3% | 3,419 | -63.4% | 0.00% | – |
Q1 2018 | $103,000 | +281.5% | 9,336 | +246.4% | 0.00% | – |
Q4 2017 | $27,000 | – | 2,695 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $11,359,000 | 18.32% |
Deer VII & Co. Ltd. | 2,263,365 | $9,212,000 | 8.07% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $13,555,000 | 3.47% |
Partner Investment Management, L.P. | 287,851 | $1,172,000 | 1.24% |
SPHERA FUNDS MANAGEMENT LTD. | 491,193 | $1,999,000 | 0.27% |
PFM Health Sciences, LP | 788,958 | $3,211,000 | 0.06% |
Perceptive Advisors | 132,300 | $538,000 | 0.01% |
Fosun International Ltd | 29,877 | $124,000 | 0.01% |
WEDBUSH SECURITIES INC | 15,400 | $63,000 | 0.01% |
Paloma Partners Management Co | 52,100 | $212,000 | 0.00% |